|
1
|
Friedman SL: Molecular regulation of
hepatic fibrosis, an integrated cellular response to tissue injury.
J Biol Chem. 275:2247–2250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pinzani M, Romanelli RG and Magli S:
Progression of fibrosis in chronic liver diseases: Time to tally
the score. J Hepatol. 34:764–767. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brenner DA, Waterboer T, Choi SK, et al:
New aspects of hepatic fibrosis. J Hepatol. 32(Suppl 1): 32–38.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schuppan D, Ruehl M, Somasundaram R and
Hahn EG: Matrix as a modulator of hepatic fibrogenesis. Semin Liver
Dis. 21:351–372. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Desmet VJ and Roskams T: Cirrhosis
reversal: A duel between dogma and myth. J Hepatol. 40:860–867.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gordillo-Bastidas D, Oceguera-Contreras E,
Salazar-Montes A, González-Cuevas J, Hernández-Ortega LD and
Armendáriz-Borunda J: Nrf2 and Snail-1 in the prevention of
experimental liver fibrosis by caffeine. World J Gastroenterol.
l9:9020–9033. 2013. View Article : Google Scholar
|
|
7
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cisneros L, Londoño MC, Blasco C, et al:
Hepatic stellate cell activation in liver transplant patients with
hepatitis C recurrence and in non-transplanted patients with
chronic hepatitis C. Liver Transpl. 13:1017–1027. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Enami Y, Bandi S, Kapoor S, Krohn N,
Joseph B and Gupta S: Hepatic stellate cells promote hepatocyte
engraftment in rat liver after prostaglandin-endoperoxide synthase
inhibition. Gastroenterology. 136:2356–2364. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wells RG: Cellular sources of
extracellular matrix in hepatic fibrosis. Clin Liver Dis.
12:759–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pellicoro A, Ramachandran P and Iredale
JP: Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 5
(Suppl 1 Proceedings of Fibroproliferative disorders: From
biochemical analysis to targeted therapies Petro E Petrides and
David Brenner). S262012.
|
|
12
|
Kim JB, Ann YH, Park SY, et al: Side
population in LX2 cells decreased by transforming growth factor-β.
Hepatol Res. 44:229–237. 2014. View Article : Google Scholar
|
|
13
|
Brenner DA: Molecular pathogenesis of
liver fibrosis. Trans Am Clin Climatol Assoc. 120:361–368.
2009.PubMed/NCBI
|
|
14
|
Bieker JJ: Krüppel-like factors: Three
fingers in many pies. J Biol Chem. 276:34355–34358. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Turner J and Crossley M: Mammalian
Krüppel-like transcription factors: More than just a pretty finger.
Trends Biochem Sci. 24:236–240. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ghaleb AM, Nandan MO, Chanchevalap S,
Dalton WB, Hisamuddin IM and Yang VW: Krüppel-like factors 4 and 5:
The yin and yang regulators of cellular proliferation. Cell Res.
15:92–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Zhao J, Liu J, Zhang H, Liu M and
Xiao X: Upregulation of the constitutively expressed HSC70 by KLF4.
Cell Stress Chaperones. 13:337–345. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fisch S, Gray S, Heymans S, et al:
Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.
Proc Natl Acad Sci USA. 104:7074–7079. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang B, Haldar SM, Lu Y, et al: The
Kruppel-like factor KLF15 inhibits connective tissue growth factor
(CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol.
45:193–197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Haldar SM, Ibrahim OA and Jain MK:
Kruppel-like Factors (KLFs) in muscle biology. J Mol Cell Cardiol.
43:1–10. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shindo T, Manabe I, Fukushima Y, et al:
Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a
target for angiotensin II signaling and an essential regulator of
cardiovascular remodeling. Nat Med. 8:856–863. 2002.PubMed/NCBI
|
|
22
|
Yet SF, McA'Nulty MM, Folta SC, et al:
Human EZF, a Krüppel-like zinc finger protein, is expressed in
vascular endothelial cells and contains transcriptional activation
and repression domains. J Biol Chem. 273:1026–1031. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen X, Johns DC, Geiman DE, et al:
Krüppel-like factor 4 (gut-enriched Krüppel-like factor) inhibits
cell proliferation by blocking G1/S progression of the cell cycle.
J Biol Chem. 276:30423–30428. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen X, Whitney EM, Gao SY and Yang VW:
Transcriptional profiling of Krüppel-like factor 4 reveals a
function in cell cycle regulation and epithelial differentiation. J
Mol Biol. 326:665–677. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang C, Han M, Zhao XM and Wen JK:
Kruppel-like factor 4 is required for the expression of vascular
smooth muscle cell differentiation marker genes induced by all
trans-retinoic acid. J Biochem. 144:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Wang Y, Liu Y, Wang N, Qi Y and
Du J: Krüppel-like factor 4 transcriptionally regulates TGF-β1 and
contributes to cardiac myofibroblast differentiation. PLoS One.
8:e634242013. View Article : Google Scholar
|
|
27
|
Levenkova N, Gu Q and Rux JJ: Gene
specific siRNA selector. Bioinformatics. 20:430–432. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Bustin SA: Absolute quantification of mRNA
using real-time reverse transcription polymerase chain reaction
assays. J Mol Endocrinol. 25:169–193. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yoshinari K, Miyagishi M and Taira K:
Effects on RNAi of the tight structure, sequence and position of
the targeted region. Nucleic Acids Res. 32:691–699. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sciabola S, Cao Q, Orozco M, Faustino I
and Stanton RV: Improved nucleic acid descriptors for siRNA
efficacy prediction. Nucleic Acids Res. 41:1383–1394. 2013.
View Article : Google Scholar :
|
|
32
|
Wang JY, Guo JS and Yang CQ: Expression of
exogenous rat collagenase in vitro and in a rat model of liver
fibrosis. World J Gastroenterol. 8:901–907. 2002.PubMed/NCBI
|
|
33
|
Dun ZN, Zhang XL, An JY, Zheng LB, Barrett
R and Xie SR: Specific shRNA targeting of FAK influenced collagen
metabolism in rat hepatic stellate cells. World J Gastroenterol.
16:4100–4106. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Moreira RK: Hepatic stellate cells and
liver fibrosis. Arch Pathol Lab Med. 131:1728–1734. 2007.PubMed/NCBI
|
|
35
|
Consolo M, Amoroso A, Spandidos DA and
Mazzarino MC: Matrix metalloproteinases and their inhibitors as
markers of inflammation and fibrosis in chronic liver disease
(Review). Int J Mol Med. 24:143–52. 2009.PubMed/NCBI
|
|
36
|
Milani S, Herbst H, Schuppan D, et al:
Differential expression of matrix-metalloproteinase-1 and -2 genes
in normal and fibrotic human liver. Am J Pathol. 144:528–537.
1994.PubMed/NCBI
|
|
37
|
Murawaki Y, Ikuta Y, Idobe Y and Kawasaki
H: Serum matrix metalloproteinase-1 in patients with chronic viral
hepatitis. J Gastroenterol Hepatol. 14:138–145. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pardo A and Selman M: MMP-1: The elder of
the family. Int J Biochem Cell Biol. 37:283–288. 2005. View Article : Google Scholar
|
|
39
|
Iimuro Y, Nishio T, Morimoto T, et al:
Delivery of matrix metalloproteinase-1 attenuates established liver
fibrosis in the rat. Gastroenterology. 124:445–458. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Birkedal-Hansen H, Moore WG, Bodden MK, et
al: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med.
4:197–250. 1993.PubMed/NCBI
|
|
41
|
Xu GF, Li PT, Wang XY, et al: Dynamic
changes in the expression of matrix metalloproteinases and their
inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in
rats. World J Gastroenterol. 10:3621–3627. 2004.PubMed/NCBI
|
|
42
|
Wang CH, Lee TH, Lu CN, et al:
Electroporative alpha-MSH gene transfer attenuates
thioacetamide-induced murine hepatic fibrosis by MMP and TIMP
modulation. Gene Ther. 13:1000–1009. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Inagaki Y and Okazaki I: Emerging insights
into Transfo rming growth factor beta Smad signal in hepatic
fibrogenesis. Gut. 56:284–292. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou J, Zhong DW, Wang QW, Miao XY and Xu
XD: Paclitaxel ameliorates fibrosis in hepatic stellate cells via
inhibition of TGF-beta-Smad activity. World J Gastroenterol.
16:3330–3334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kondou H, Mushiake S, Etani Y, Miyoshi Y,
Michigami T and Ozono K: A Blocking peptide for transforming growth
factor-beta 1 activation prevents hepatic fibrosis in vivo. J
Hepatol. 39:742–748. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Okuno M, Akita K, Moriwaki H, et al:
Prevention of rat hepatic fibrosis by the protease inhibitor,
camostat mesilate, via reduced generation of active TGF-beta.
Gastroenterology. 120:1784–1800. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Marchetti L, Klein M, Schlett K,
Pfizenmaier K and Eisel UL: Tumor necrosis factor (TNF)-mediated
neuroprotection against glutamate-induced excitotoxicity is
enhanced by N-methyl D-aspartate receptor activation. Essential
role of a TNF receptor 2-mediated phosphatidylinositol
3-kinase-dependent NF-kappa B pathway. J Biol Chem.
279:32869–32881. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bortolami M, Kotsafti A, Cardin R and
Farinati F: Fas/FasL system, IL-1beta expression and apoptosis in
chronic HBV and HCV liver disease. J Viral Hepat. 15:515–522. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Saile B and Ramadori G: Inflammation,
damage repair and liver fibrosis – role of cytokines and different
cell types. Z Gastroenterol. 45:77–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
